Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Quotient Ltd

Resubmit Initial SDS microarray for FDA 510(k)

Not delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
1 Feb 2021
Due
30 Jun 2021
Checked
25 Oct 2026
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“US FDA 510(k) resubmission is planned in Q2 CY2021”
  • SourceQuotient Ltd Form 8-K press release, 2021-02-01
  • FilingSEC filing index
  • Deadline as statedQ2 CY2021
  • Deadline used30 Jun 2021, the last day of the stated period
  • TypeRegulatory
  • Permanent referenceKI-C-2021-C596946-022763
    Cite as https://keptindex.org/c/KI-C-2021-C596946-022763/ — this address never changes.

What we found

Evidence strength A What the grades mean

The company did not resubmit the initial SDS microarray 510(k) by the Q2 2021 deadline, subsequently pushing the anticipated resubmission date to the end of 2021.

  • A
    Quotient Ltd 10-Q filed 2021-08-05 Regulatory filing · published 5 Aug 2021 · retrieved 25 Oct 2026 · kept permanently by the SEC · fingerprint 88a2f82b8073
    “We anticipate that we will resubmit our filing for 510(k) clearance for the initial MosaiQ SDS Microarray around year-end of calendar year 2021.” ✓ confirmed on the page

Checked 25 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Regulatory other
Indicative materiality
Medium rules
Action
Resubmit
Deliverable
FDA 510(k) resubmission
Where
United States
Language
Expected (“expects”, “plans”)
In the company’s control
High
Specificity
High
Depends on
Regulatory

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
  4. Third check on a negative finding: agreesBecause a negative finding could harm a company if wrong, a stronger model re-read the evidence fully blind and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Quotient Ltd? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-C596946-022763 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.